By Kyle Brasseur2023-07-19T21:39:00
New draft merger guidance put forward by the Department of Justice (DOJ) and Federal Trade Commission (FTC) continues the agencies’ joint mission to modernize antitrust enforcement.
The guidance, published Wednesday, is open for public comment through Sept. 18. Within it are 13 guidelines the agencies said they might use when determining whether a merger is unlawfully anticompetitive under antitrust laws.
The guidelines reflect the most common issues that arise in merger reviews, according to a DOJ fact sheet. They detail the agencies’ focus on areas including:
2023-12-18T20:48:00Z By Kyle Brasseur
A long-running initiative by the Department of Justice and Federal Trade Commission to modernize their joint merger guidelines reached its conclusion, following tens of thousands of public comments.
2023-10-27T16:25:00Z By Kyle Brasseur
It’s no secret the U.S. healthcare competition system has significant flaws. Where the debate exists is in determining the source of the issues and how to fix them, according to Deputy Assistant Attorney General Andrew Forman of the Department of Justice’s Antitrust Division.
2023-09-21T20:38:00Z By Kyle Brasseur
The Department of Justice is gearing up to provide more guidance on voluntary self-disclosures in the mergers and acquisitions space and the role compliance should play.
2025-10-15T19:43:00Z By Jaclyn Jaeger
Under the Trump administration, the Department of Health and Human Services and the Food and Drug Administration have been hellbent on eliminating synthetic food dyes from food and beverage products, forcing a jarring and costly overhaul with cascading impacts on the operations of the entire industry.
2025-10-08T20:08:00Z By Ruth Prickett
Private companies that are keen to trade their shares but do not wish to become listed have gained another way to trade their shares. The U.K. government completed its initial review and published rules for the system in June.
2025-10-03T21:24:00Z By Adrianne Appel
While the Trump administration may have shifted away from pursuing small, white-collar, financial crimes, its focus on health care fraud cases is as hot as ever.
Site powered by Webvision Cloud